GeneTether Therapeutics (XCNQ:GTTX) Other Operating Expense : C$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is GeneTether Therapeutics Other Operating Expense?

GeneTether Therapeutics's Other Operating Expense for the three months ended in Dec. 2023 was C$0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

GeneTether Therapeutics's quarterly Other Operating Expense declined from Jun. 2023 (C$0.00 Mil) to Sep. 2023 (C$0.00 Mil) but then increased from Sep. 2023 (C$0.00 Mil) to Dec. 2023 (C$0.00 Mil).

GeneTether Therapeutics's annual Other Operating Expense increased from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$0.00 Mil) but then declined from Dec. 2022 (C$0.00 Mil) to Dec. 2023 (C$0.00 Mil).

GeneTether Therapeutics Other Operating Expense Historical Data

The historical data trend for GeneTether Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneTether Therapeutics Other Operating Expense Chart

GeneTether Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

GeneTether Therapeutics Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial								-	-	-	-	-

GeneTether Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

GeneTether Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of GeneTether Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneTether Therapeutics (XCNQ:GTTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneTether Therapeutics Inc (XCNQ:GTTX) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, V1Y 2B3

Website

https://www.genetether.com

GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin.

GeneTether Therapeutics (XCNQ:GTTX) Headlines

No Headlines